Literature DB >> 18261958

The convergent roles of tapasin and HLA-DM in antigen presentation.

Scheherazade Sadegh-Nasseri1, Mingnan Chen, Kedar Narayan, Marlene Bouvier.   

Abstract

Cytotoxic and helper T cells respond to peptides derived from endogenous and exogenous sources that bind to major histocompatibility complex (MHC) class I and class II molecules and are presented on antigen-presenting cells. MHC class I and class II structures and maturation pathways have evolved to optimize antigen presentation to their respective T cells. The accessory proteins tapasin and HLA-DM (DM) crucially influence the selection of peptides that bind to the MHC molecules. We discuss here the dynamic interactions of tapasin and DM with their corresponding MHC molecules that indicate striking parallels. Utilization of a common mode of peptide selection by two different, but related, biological systems argue for its mechanistic validity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261958      PMCID: PMC3075112          DOI: 10.1016/j.it.2008.01.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  53 in total

1.  "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules.

Authors:  Viviana Marin-Esteban; Kirsten Falk; Olaf Rötzschke
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

2.  Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping.

Authors:  Gregory J Carven; Lawrence J Stern
Journal:  Biochemistry       Date:  2005-10-25       Impact factor: 3.162

3.  Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin.

Authors:  Alexandra Kienast; Marc Preuss; Monique Winkler; Tobias P Dick
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

4.  Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing.

Authors:  J C Solheim; M R Harris; C S Kindle; T H Hansen
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

5.  HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.

Authors:  Kedar Narayan; Chih-Ling Chou; AeRyon Kim; Isamu Z Hartman; Sarat Dalai; Stanislav Khoruzhenko; Scheherazade Sadegh-Nasseri
Journal:  Nat Immunol       Date:  2006-12-03       Impact factor: 25.606

6.  HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.

Authors:  L K Denzin; P Cresswell
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

7.  Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection.

Authors:  Mingnan Chen; Marlene Bouvier
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

8.  Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.

Authors:  D A Weber; B D Evavold; P E Jensen
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

9.  Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer.

Authors:  Pamela A Wearsch; Peter Cresswell
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

10.  Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes.

Authors:  A J Sijts; E G Pamer
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

View more
  20 in total

Review 1.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 2.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

Review 3.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

Review 4.  The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.

Authors:  Monika-Sarah E D Schulze; Kai W Wucherpfennig
Journal:  Curr Opin Immunol       Date:  2011-12-02       Impact factor: 7.486

5.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

6.  HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1.

Authors:  Kedar Narayan; Katherine W Su; Chih-Ling Chou; Stanislav Khoruzhenko; Scheherazade Sadegh-Nasseri
Journal:  Mol Immunol       Date:  2009-07-31       Impact factor: 4.407

Review 7.  Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.

Authors:  Scheherazade Sadegh-Nasseri; Sateesh Natarajan; Chih-Ling Chou; Isamu Z Hartman; Kedar Narayan; AeRyon Kim
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 8.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

9.  Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.

Authors:  Wouter Pos; Dhruv K Sethi; Melissa J Call; Monika-Sarah E D Schulze; Anne-Kathrin Anders; Jason Pyrdol; Kai W Wucherpfennig
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

10.  Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer.

Authors:  Gang Dong; Pamela A Wearsch; David R Peaper; Peter Cresswell; Karin M Reinisch
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.